A. Massie

发表

Liver sharing and organ procurement organization performance

A. Israni, B. Kasiske, D. Segev, 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Liver sharing and organ procurement organization performance under redistricted allocation

A. Israni, B. Kasiske, D. Segev, 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Addressing Geographic Disparities in Liver Transplantation Through Redistricting

M. Schnitzler, D. Segev, S. Gentry, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Validating Cortical Surface Analysis of Medial Prefrontal Cortex

J. T. Ratnanather, M. Miller, M. Miller, 2001, NeuroImage.

Rising Cost of Thyroid Surgery in Adult Patients.

Martha A. Zeiger, Allan Massie, D. Segev, 2020, The Journal of surgical research.

Here Comes the Sunshine: Industry's Payments to Cardiothoracic Surgeons.

R. Higgins, D. Segev, E. Chow, 2017, The Annals of thoracic surgery.

Organs from deceased donors with false‐positive HIV screening tests: An unexpected benefit of the HOPE act

D. Segev, A. Massie, P. Stock, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Machine learning to predict transplant outcomes: helpful or hype? A national cohort study

B. Caffo, D. Segev, A. Massie, 2020, Transplant international : official journal of the European Society for Organ Transplantation.

Assessment of Trends in Transplantation of Liver Grafts From Older Donors and Outcomes in Recipients of Liver Grafts From Older Donors, 2003-2016.

D. Segev, A. Massie, Xun Luo, 2019, JAMA surgery.

Pretransplant Hepatitis C Virus Treatment Decreases Access to High-quality Livers

Sharon R. Weeks, S. Weeks, D. Segev, 2021, Transplantation direct.

Expansion of the Liver Donor Supply Through Greater Use of Split‐Liver Transplantation: Identifying Optimal Recipients

D. Segev, A. Massie, Xun Luo, 2019, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Minimizing Risk Associated With Older Liver Donors by Matching to Preferred Recipients: A National Registry and Validation Study

D. Segev, A. Massie, C. Haugen, 2018, Transplantation.

HOPE in action: A prospective multicenter pilot study of liver transplantation from donors with HIV to recipients with HIV

Cameron R. Wolfe, T. Quinn, D. Segev, 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Quantifying the Risk of Incompatible Kidney Transplantation: A Multicenter Study

M. Stegall, D. Gerber, M. Rees, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Incidence and Outcomes of COVID-19 in Kidney and Liver Transplant Recipients With HIV: Report From the National HOPE in Action Consortium.

D. Segev, A. Massie, A. Tobian, 2020, Transplantation.

Outcomes of living liver donor candidate evaluations in the Living Donor Collective pilot registry

A. Israni, B. Kasiske, M. Dew, 2021, Clinical transplantation.

Barriers to access in pediatric living‐donor liver transplantation

D. Segev, A. Massie, J. Bridges, 2019, Pediatric transplantation.

Prescription Patterns of Opioids and Non-Steroidal Anti-Inflammatory Drugs in the First Year After Living Kidney Donation: An Analysis of U.S. Registry and Pharmacy Fill Records.

A. Garg, B. Kasiske, M. Schnitzler, 2020, Clinical transplantation.

Associations of obesity with antidiabetic medication use after living kidney donation: An analysis of linked national registry and pharmacy fill records

A. Garg, B. Kasiske, M. Schnitzler, 2019, Clinical transplantation.

Obesity and long-term mortality risk among living kidney donors.

C. Lewis, D. Segev, J. Snyder, 2019, Surgery.

Experiences Obtaining Insurance After Live Kidney Donation

D. Segev, R. Montgomery, N. Deshpande, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Patterns of End‐Stage Renal Disease Caused by Diabetes, Hypertension, and Glomerulonephritis in Live Kidney Donors

A. Garg, D. Segev, A. Massie, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Kidney Transplantation Confers Survival Benefit for Candidates With Pulmonary Hypertension

D. Segev, A. Massie, D. Brennan, 2021, Transplantation direct.

Outcomes of Living Kidney Donor Candidate Evaluations in the Living Donor Collective Pilot Registry

A. Israni, B. Kasiske, M. Dew, 2021, Transplantation Direct.

Long‐term renal function in living kidney donors with simple renal cysts: A retrospective cohort study

A. Q. Nguyen, D. Segev, A. Massie, 2020, Clinical transplantation.

Association of Early Postdonation Renal Function With Subsequent Risk of End-Stage Renal Disease in Living Kidney Donors.

A. Garg, D. Segev, J. Snyder, 2020, JAMA surgery.

The Influence of Antithymocyte Globulin Dose on the Incidence of CMV Infection in High-risk Kidney Transplant Recipients Without Pharmacological Prophylaxis

D. Segev, A. Massie, H. Tedesco-Silva, 2020, Transplantation.

Postdonation eGFR and New-Onset Antihypertensive Medication Use After Living Kidney Donation

A. Garg, B. Kasiske, M. Schnitzler, 2019, Transplantation direct.

A donor risk index for graft loss in pediatric living donor kidney transplantation

D. Segev, A. Massie, A. Neu, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Living donor postnephrectomy kidney function and recipient graft loss: A dose‐response relationship

D. Segev, A. Massie, M. Henderson, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Recipient Outcomes Following Transplantation of Allografts From Live Kidney Donors Who Subsequently Developed End‐Stage Renal Disease

A. Garg, D. Segev, A. Massie, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Risk of ESKD in related older living kidney donors

D. Segev, A. Massie, J. Garonzik-Wang, 2022, medRxiv.

Baseline and Center-Level Variation in Simultaneous Liver-Kidney Listing in the United States

D. Segev, A. Massie, Xun Luo, 2017, Transplantation.

National Variation in Use of Immunosuppression for Kidney Transplantation: A Call for Evidence‐Based Regimen Selection

M. Schnitzler, D. Segev, D. Axelrod, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Early Changes in Kidney Transplant Immunosuppression Regimens During the COVID-19 Pandemic.

D. Segev, A. Massie, K. Lentine, 2020, Transplantation.

Perceived Susceptibility to Chronic Kidney Disease and Hypertension Self-Management among Black and White Live Kidney Donors.

Tanjala S. Purnell, D. Segev, A. Massie, 2022, Ethnicity & disease.

Changes in offer and acceptance patterns for pediatric kidney transplant candidates under the new Kidney Allocation System

D. Segev, A. Massie, M. Bowring, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Machine perfusion and long-term kidney transplant recipient outcomes across allograft risk strata

D. Segev, A. Massie, Xun Luo, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Survival Benefit of Primary Deceased Donor Transplantation With High‐KDPI Kidneys

D. Segev, E. Chow, A. Massie, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Impact of the COVID-19 pandemic on transplantation by income level and cumulative COVID-19 incidence: a multinational survey study

D. Segev, A. Massie, K. Thavorn, 2022, BMJ Open.

Concurrent Oral Sessions: Liver

D. Segev, S. Gentry, A. Massie, 2014 .

Language impairment in adults with end-stage liver disease: application of natural language processing towards patient-generated health records

Masoud Rouhizadeh, D. Segev, A. Massie, 2019, npj Digital Medicine.

Kidney offer acceptance at programs undergoing a Systems Improvement Agreement

D. Segev, A. Massie, R. Craig-Schapiro, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Landscape of Deceased Donors Labeled Increased Risk for Disease Transmission Under New Guidelines

L. Kucirka, D. Segev, A. Massie, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Identifying Appropriate Recipients for CDC Infectious Risk Donor Kidneys

H. Lehmann, L. Kucirka, D. Segev, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Identifying Appropriate Recipients for CDC Infectious Risk Donor Kidneys: Recipients for Infectious Risk Donor Kidneys

H. Lehmann, L. Kucirka, D. Segev, 2013 .

Effect of eliminating priority points for HLA-B matching on racial disparities in kidney transplant rates.

D. Segev, R. Montgomery, A. Massie, 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients

D. Segev, A. Massie, A. Tobian, 2021, Transplantation.

A cluster-randomized, placebo-controlled, maternal vitamin a or beta-carotene supplementation trial in bangladesh: design and methods

A. Massie, A. Labrique, R. Klemm, 2011, Trials.

Induction immunosuppression agents as risk factors for incident cardiovascular events and mortality after kidney transplantation

D. Segev, A. Massie, K. Lentine, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series

D. Segev, A. Massie, A. Tobian, 2021, Annals of Internal Medicine.

The effect of the cystic fibrosis care center on outcomes after lung transplantation for cystic fibrosis.

R. Higgins, P. Shah, C. Merlo, 2021, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

PASC in Solid Organ Transplant Recipients With Self-reported SARS-CoV-2 Infection

T. Vannorsdall, D. Segev, A. Massie, 2022, Transplantation.

Delayed graft function and acute rejection following HLA‐incompatible living donor kidney transplantation

Jane J. Long, M. Stegall, D. Gerber, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Mitochondrial membrane potential and delayed graft function following kidney transplantation

D. Segev, A. Massie, Xun Luo, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Low utilization of adult-to-adult LDLT in Western countries despite excellent outcomes: international multicenter analysis of the US, UK, and Canada.

D. Segev, A. Massie, N. Selzner, 2022, Journal of hepatology.

Predicting a Positive Antibody Response After 2 SARS-CoV-2 mRNA Vaccines in Transplant Recipients: A Machine Learning Approach With External Validation

A. Gaber, D. Segev, D. Warren, 2022, Transplantation.

Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients

D. Segev, A. Massie, R. Avery, 2021, Transplantation.

Early Hypertension and Diabetes after Living Kidney Donation: A National Cohort Study.

D. Segev, A. Massie, K. Lentine, 2019, Transplantation.

The Dawn of Transparency: Insights from the Physician Payment Sunshine Act in Plastic Surgery

J. May, D. Segev, E. Chow, 2017, Annals of plastic surgery.

Where the Sun Shines: Industry's Payments to Transplant Surgeons

D. Segev, E. Chow, A. Massie, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Characterizing the landscape and impact of infections following kidney transplantation

Jane J. Long, D. Segev, A. Massie, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.

D. Segev, A. Massie, A. Tobian, 2021, JAMA.

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients.

D. Segev, A. Massie, A. Tobian, 2021, JAMA.

Outcomes of Live Kidney Donors Who Develop End-Stage Renal Disease

L. Kucirka, D. Segev, R. Montgomery, 2016, Transplantation.

Long-term Renal Function in Living Kidney Donors Who Had Histological Abnormalities at Donation

D. Segev, R. Montgomery, A. Massie, 2016, Transplantation.

Temporal Changes in the Impact of HLA Mismatching Among Pediatric Kidney Transplant Recipients.

D. Segev, A. Massie, A. Jackson, 2019, Transplantation.

The Landscape of Nondirected Living Liver Donation in the United States

Tanjala S. Purnell, D. Segev, A. Massie, 2022, Transplantation.

Survival benefit of accepting kidneys from older donation after cardiac death donors

Jane J. Long, D. Segev, A. Massie, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Factors associated with poor antibody response to third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases

Ami A. Shah, J. Albayda, D. Segev, 2022, The Lancet Rheumatology.

The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases.

A. Massie, R. Ambinder, C. Durand, 2016, Blood.

Financial incentives versus standard of care to improve patient compliance with live kidney donor follow-up: protocol for a multi-center, parallel-group randomized controlled trial

D. Segev, A. Massie, D. Brennan, 2020, BMC Nephrology.

Temporal trends in utilization and outcomes of steatotic donor livers in the United States

Jane J. Long, D. Segev, A. Massie, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Liver transplantation in the United States during the COVID-19 pandemic: National and center-level responses

D. Segev, J. Snyder, T. Baker, 2020, American Journal of Transplantation.

Response to “non‐local kidney transplantation and transplant outcomes”

D. Segev, J. Snyder, D. Axelrod, 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Prevalence and Durability of SARS-CoV-2 Antibodies Among Unvaccinated US Adults by History of COVID-19.

M. Makary, D. Segev, A. Massie, 2022, JAMA.

Effects of COVID-19 pandemic on pediatric kidney transplant in the United States

D. Segev, A. Massie, R. Avery, 2020, Pediatric Nephrology.

Effect of maternal multiple micronutrient vs iron-folic acid supplementation on infant mortality and adverse birth outcomes in rural Bangladesh: The JiVitA-3 randomized trial

A. Massie, A. Labrique, R. Klemm, 2015 .

Omicron BA.1 and BA.2 Neutralizing Activity Following Pre-Exposure Prophylaxis with Tixagevimab plus Cilgavimab in Vaccinated Solid Organ Transplant Recipients

D. Segev, D. Warren, A. Massie, 2022, medRxiv.

Quantifying excess deaths among solid organ transplant recipients in the COVID‐19 era

D. Segev, J. Snyder, A. Massie, 2022, American Journal of Transplantation.

Antibody Response to a Fourth Dose of a SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series

D. Segev, A. Massie, A. Tobian, 2021, Transplantation.

Donor-Recipient Relationship and Risk of ESKD in Live Kidney Donors of Varied Racial Groups.

Tanjala S. Purnell, D. Segev, J. Snyder, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The changing landscape of live kidney donation in the United States from 2005 to 2017

D. Segev, A. Massie, D. Brennan, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Impact of ABO-Incompatible Living Donor Kidney Transplantation on Patient Survival.

A. Q. Nguyen, D. Segev, R. Montgomery, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

How do highly sensitized patients get kidney transplants in the United States? Trends over the last decade

D. Segev, A. Massie, N. Desai, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The Incremental Cost of Incompatible Living Donor Kidney Transplantation: A National Cohort Analysis

M. Stegall, M. Schnitzler, D. Gerber, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Risk Assessment Tools and Innovations in Living Kidney Donation

D. Segev, A. Massie, A. Muzaale, 2021 .

The Living Donor Collective: A Scientific Registry for Living Donors

A. Israni, M. Dew, A. Waterman, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Quantifying Postdonation Risk of ESRD in Living Kidney Donors.

A. Q. Nguyen, D. Segev, J. Snyder, 2017, Journal of the American Society of Nephrology : JASN.

The Authors Reply.

D. Segev, A. Massie, R. Reed, 2017, Kidney international.

Kidney donation and risk of ESRD--reply.

D. Segev, A. Massie, A. Muzaale, 2014, Journal of the American Medical Association (JAMA).

Interviews of living kidney donors to assess donation-related concerns and information-gathering practices

D. Segev, A. Massie, M. Henderson, 2018, BMC Nephrology.

Factors associated with perceived donation‐related financial burden among living kidney donors

D. Segev, A. Massie, M. Henderson, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Decreased incidence of acute rejection without increased incidence of cytomegalovirus (CMV) infection in kidney transplant recipients receiving rabbit anti‐thymocyte globulin without CMV prophylaxis – a cohort single‐center study

D. Segev, A. Massie, H. Tedesco-Silva, 2020, Transplant international : official journal of the European Society for Organ Transplantation.

Outcomes after kidney donation.

D. Segev, A. Massie, A. Muzaale, 2014, JAMA.

Early Changes in Kidney Distribution under the New Allocation System.

D. Segev, A. Massie, Xun Luo, 2016, Journal of the American Society of Nephrology : JASN.

Center‐Level Patterns of Indicated Willingness to and Actual Acceptance of Marginal Kidneys

D. Segev, R. Montgomery, A. Massie, 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Projected 20- and 30-Year Outcomes for Pediatric Liver Transplant Recipients in the United States.

D. Segev, A. Massie, J. Bridges, 2019, Journal of pediatric gastroenterology and nutrition.

Association of race and age with survival among patients undergoing dialysis.

L. Kucirka, J. Lessler, D. Segev, 2011, JAMA.

Risk of end-stage renal disease following live kidney donation.

Mei-Cheng Wang, D. Segev, R. Montgomery, 2014, JAMA.

Examination of Racial and Ethnic Differences in Deceased Organ Donation Ratio Over Time in the US.

Tanjala S. Purnell, D. Segev, A. Massie, 2021, JAMA surgery.

Willingness to Donate Organs Among People Living With HIV

A. Q. Nguyen, D. Segev, A. Massie, 2018, Journal of acquired immune deficiency syndromes.

Early impact of COVID-19 on transplant center practices and policies in the United States

D. Segev, A. Massie, R. Avery, 2020, American Journal of Transplantation.

Transplantation Amid a Pandemic: The Fall and Rise of Kidney Transplantation in the United States

D. Segev, J. Snyder, A. Massie, 2022, Transplantation direct.

Evolving Impact of COVID‐19 on Transplant Center Practices and Policies in the United States

D. Segev, T. Baker, A. Massie, 2020, Clinical transplantation.

Early Experiences With COVID-19 Testing in Transplantation

D. Segev, A. Massie, R. Avery, 2020, Transplantation direct.

Identifying scenarios of benefit or harm from kidney transplantation during the COVID-19 pandemic: A stochastic simulation and machine learning study

D. Segev, E. Chow, A. Massie, 2020, American Journal of Transplantation.

Early national and center-level changes to kidney transplantation in the United States during the COVID-19 epidemic

D. Segev, J. Snyder, A. Massie, 2020, American Journal of Transplantation.

Early Changes in Liver Distribution Following Implementation of Share 35

D. Segev, S. Gentry, E. Chow, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys

L. Kucirka, D. Segev, S. Gentry, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Impact of Race and Ethnicity on Outcomes for Children Waitlisted for Pediatric Liver Transplantation

D. Segev, E. Chow, A. Massie, 2017, Journal of pediatric gastroenterology and nutrition.

Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy

L. Kucirka, D. Segev, A. Massie, 2018, Transplantation.

The National Landscape of Living Kidney Donor Follow‐Up in the United States

Tanjala S. Purnell, D. Segev, A. Massie, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors.

M. Stegall, D. Gerber, A. Gaber, 2016, The New England journal of medicine.

Posttransplant Outcomes for cPRA-100% Recipients Under the New Kidney Allocation System

D. Segev, A. Massie, N. Desai, 2019, Transplantation.

The national landscape of deceased donor kidney transplantation for the highly sensitized: Transplant rates, waitlist mortality, and posttransplant survival under KAS

D. Segev, A. Massie, Xun Luo, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Temporal Trends in Utilization and Outcomes of DCD Livers in the United States

D. Segev, A. Massie, A. Gurakar, 2021, Transplantation.

Examination of Racial and Socioeconomic Disparity in Use of Nondirected Kidney Donation in the US.

D. Segev, A. Massie, A. Cameron, 2022, Journal of the American College of Surgeons.

Kidney Transplant Recipient Attitudes Toward a SARS-CoV-2 Vaccine

D. Segev, A. Massie, M. Cooper, 2021, Transplantation direct.

Effects of vitamin A or beta carotene supplementation on pregnancy-related mortality and infant mortality in rural Bangladesh: a cluster randomized trial.

A. Sommer, J. Katz, A. Massie, 2011, JAMA.

Determinants of length of stay after pediatric liver transplantation

D. Segev, A. Massie, Xun Luo, 2020, Pediatric transplantation.

Obesity increases the risk of end-stage renal disease among living kidney donors.

C. Lewis, D. Segev, A. Massie, 2017, Kidney international.

Fifteen‐Year Trends in Pediatric Liver Transplants: Split, Whole Deceased, and Living Donor Grafts

D. Segev, E. Chow, A. Massie, 2018, The Journal of pediatrics.

Deceased-Donor Liver Size and the Sex-Based Disparity in Liver Transplantation.

D. Segev, S. Gentry, A. Massie, 2017, Transplantation.

Waitlist Outcomes of Liver Transplant Candidates Who Were Reprioritized Under Share 35

D. Segev, S. Gentry, E. Chow, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Impact of broader sharing on the transport time for deceased donor livers

D. Segev, S. Gentry, E. Chow, 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United States

L. Kucirka, D. Segev, A. Massie, 2018, Annals of Internal Medicine.

Changes in Utilization and Discard of Hepatitis C–Infected Donor Livers in the Recent Era

L. Kucirka, D. Segev, A. Massie, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Inpatient COVID-19 outcomes in solid organ transplant recipients compared to non-solid organ transplant patients: A retrospective cohort

M. Makary, P. Shah, D. Segev, 2020, American Journal of Transplantation.

Survival Benefit of Split‐Liver Transplantation for Pediatric and Adult Candidates

D. Segev, A. Massie, A. Cameron, 2021, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Racial differences in completion of the living kidney donor evaluation process

D. Segev, E. Chow, A. Massie, 2018, Clinical transplantation.

Association of Race and Ethnicity With Live Donor Kidney Transplantation in the United States From 1995 to 2014

Xun Luo, Lisa A. Cooper, Elisa J. Gordon, 2018, JAMA.

A Smartphone App for Increasing Live Organ Donation

D. Segev, A. Massie, K. Bramstedt, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

National Variation in Increased Infectious Risk Kidney Offer Acceptance.

D. Segev, S. Gentry, A. Massie, 2019, Transplantation.

A prospective multicenter pilot study of HIV‐positive deceased donor to HIV‐positive recipient kidney transplantation: HOPE in action

Cameron R. Wolfe, T. Quinn, D. Segev, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Willingness to Accept HIV-infected and Increased Infectious Risk Donor Organs among Transplant Candidates Living with HIV.

A. Q. Nguyen, F. Fletcher, D. Segev, 2020, Journal of acquired immune deficiency syndromes.

Center‐level trends in utilization of HCV‐exposed donors for HCV‐uninfected kidney and liver transplant recipients in the United States

D. Segev, A. Massie, M. Sulkowski, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Knowledge, attitudes, and planned practice of HIV‐positive to HIV‐positive transplantation in US transplant centers

D. Segev, A. Massie, A. Tobian, 2018, Clinical transplantation.

Access to Kidney Transplantation among HIV-Infected Waitlist Candidates.

M. Saag, D. Segev, A. Massie, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus–Infected Recipients

D. Segev, A. Massie, P. MacLennan, 2016, Transplantation.

Survival Benefit of Kidney Transplantation in HIV-infected Patients

D. Segev, J. Snyder, A. Massie, 2017, Annals of surgery.

A National Study of Outcomes among HIV-Infected Kidney Transplant Recipients.

D. Segev, A. Massie, P. MacLennan, 2015, Journal of the American Society of Nephrology : JASN.

Risk of End‐Stage Renal Disease in HIV‐Positive Potential Live Kidney Donors

L. Kucirka, S. Boswell, M. Gill, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Development of a Patient Reported Measure of Experimental Transplants with HIV and Ethics in the United States (PROMETHEUS)

D. Segev, A. Massie, A. Tobian, 2021, Journal of Patient-Reported Outcomes.

Trends in the survival benefit of repeat -kidney transplantation over the past three decades.

D. Segev, A. Massie, M. McAdams‐DeMarco, 2023, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Higher Mortality in registrants with sudden model for end‐stage liver disease increase: Disadvantaged by the current allocation policy

D. Segev, A. Massie, Xun Luo, 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Changes in Discard Rate After the Introduction of the Kidney Donor Profile Index (KDPI)

D. Segev, A. Massie, S. Bae, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Taking Belatacept

D. Segev, A. Massie, A. Tobian, 2021, Transplantation.

Kidney exchange match rates in a large multicenter clearinghouse

A. Waterman, D. Segev, S. Gentry, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Panel-reactive Antibody and the Association of Early Steroid Withdrawal With Kidney Transplant Outcomes

J. Coresh, D. Segev, A. Massie, 2021, Transplantation.

Bayesian Construction of Geometrically Based Cortical Thickness Metrics

Michael I. Miller, J. Tilak Ratnanather, John G. Csernansky, 2000, NeuroImage.

Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients.

D. Segev, A. Massie, R. Avery, 2021, Transplantation.

Listing at non‐local transplant centers is associated with increased access to deceased donor kidney transplantation

D. Segev, J. Snyder, D. Axelrod, 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Don't stop thinking about tomorrow: Ascertainment bias in pre‐post design transplant registry studies

D. Segev, A. Massie, J. Motter, 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Geographic disparity in kidney transplantation under KAS

D. Segev, S. Gentry, E. Chow, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Better Understanding the Disparity Associated With Black Race in Heart Transplant Outcomes: A National Registry Analysis.

R. Higgins, C. Merlo, D. Segev, 2021, Circulation. Heart failure.

Antibody Response to the Janssen COVID-19 Vaccine in Solid Organ Transplant Recipients.

D. Segev, A. Massie, William Werbel, 2021, Transplantation.

Pediatric deceased donor kidney transplant outcomes under the Kidney Allocation System

D. Segev, A. Massie, A. Neu, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Decreasing deceased donor transplant rates among children (≤6 years) under the new kidney allocation system

D. Segev, A. Massie, C. Young, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

The unfinished journey toward transplant equity: an analysis of racial/ethnic disparities for children after the implementation of the Kidney Allocation System in 2014

D. Segev, A. Massie, A. Goldberg, 2022, Pediatric Nephrology.

Big Data in Organ Transplantation: Registries and Administrative Claims

D. Segev, A. Massie, L. M. Kuricka, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Anti-Thymocyte Globulin versus Interleukin-2 Receptor Antagonist in Kidney Transplant Recipients with Hepatitis C Virus.

J. Coresh, L. Kucirka, D. Segev, 2020, Transplantation.

Landscape of Living Multiorgan Donation in the United States: A Registry-Based Cohort Study.

D. Segev, A. Massie, K. Lentine, 2018, Transplantation.

Eplet mismatches associated with de novo donor-specific HLA antibody in pediatric kidney transplant recipients

D. Segev, A. Massie, M. Philogene, 2020, Pediatric Nephrology.

Impact of the COVID-19 pandemic on commercial airlines in the United States and implications for the kidney transplant community

D. Segev, J. Snyder, A. Massie, 2020, American Journal of Transplantation.

Social Media and Organ Donor Registration: The Facebook Effect

D. Segev, R. Montgomery, A. Massie, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Rates of False Flagging Due to Statistical Artifact in CMS Evaluations of Transplant Programs: Results of a Stochastic Simulation

D. Segev, A. Massie, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Inconsistencies in the association of clinical factors with the choice of early steroid withdrawal across kidney transplant centers: A national registry study

J. Coresh, D. Segev, A. Massie, 2020, Clinical transplantation.

National Transplant Data Registries and Population Studies

D. Segev, A. Massie, 2014 .

Perceived frailty and measured frailty among adults undergoing hemodialysis: a cross-sectional analysis

D. Segev, A. Massie, J. Walston, 2015, BMC Geriatrics.

Perspectives on implementing mobile health technology for living kidney donor follow‐up: In‐depth interviews with transplant providers

Tanjala S. Purnell, D. Segev, A. Massie, 2019, Clinical transplantation.

The Impact of the mKidney mHealth System on Live Donor Follow-Up Compliance: Protocol for a Randomized Controlled Trial

D. Segev, A. Massie, A. Bingaman, 2019, JMIR research protocols.

Assessing the Attitudes and Perceptions Regarding the Use of Mobile Health Technologies for Living Kidney Donor Follow-Up: Survey Study

D. Segev, A. Massie, K. Lentine, 2018, JMIR mHealth and uHealth.

Patterns of primary care utilization before and after living kidney donation

Tanjala S. Purnell, D. Segev, A. Massie, 2017, Clinical transplantation.

After Kidney Donation CKD , Chronic Kidney Disease ESRD , End Stage Renal Disease LKD , Live Kidney Donation PCP , Primary Care Provider

D. Segev, A. Massie, Xun Luo, 2017 .

Comparison of SARS-CoV-2 Antibody Response After 2-Dose mRNA-1273 vs BNT162b2 Vaccines in Incrementally Immunosuppressed Patients

D. Segev, A. Massie, J. Alejo, 2022, JAMA network open.

Shipping living donor kidneys and transplant recipient outcomes

A. Waterman, D. Segev, M. Melcher, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Immunogenicity of Ad26.COV2.S prime and two subsequent doses of mRNA SARS‐CoV‐2 vaccines in solid organ transplant recipients: A case series

D. Segev, D. Warren, A. Massie, 2022, Clinical transplantation.

Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination

D. Segev, D. Warren, A. Massie, 2022, American Journal of Transplantation.

SARS-CoV-2 messenger RNA vaccine antibody response and reactogenicity in heart and lung transplant recipients

R. Higgins, P. Shah, D. Segev, 2021, The Journal of Heart and Lung Transplantation.

Effect of Mycophenolate Mofetil Dosing on Antibody Response to SARS-CoV-2 Vaccination in Heart and Lung Transplant Recipients.

D. Segev, D. Warren, A. Massie, 2022, Transplantation.

SARS-CoV-2 Messenger RNA Vaccine Immunogenicity in Solid Organ Transplant Recipients With Prior COVID-19

D. Segev, A. Massie, R. Avery, 2021, Transplantation.

A Risk Index for Living Donor Kidney Transplantation

D. Segev, E. Chow, A. Massie, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Candidacy for Kidney Transplantation of Older Adults

L. Kucirka, D. Segev, R. Montgomery, 2012, Journal of the American Geriatrics Society.

Long‐term kidney function and survival in recipients of allografts from living kidney donors with hypertension: a national cohort study

B. Caffo, P. Welling, D. Segev, 2021, Transplant international : official journal of the European Society for Organ Transplantation.

The first increase in live kidney donation in the United States in 15 years

D. Segev, A. Massie, M. Henderson, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Better graft outcomes from offspring donor kidneys among living donor kidney transplant recipients in the United States

Tanjala S. Purnell, D. Segev, A. Massie, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Association between Living Kidney Donor Post-Donation Hypertension and Recipient Graft Failure.

D. Segev, A. Massie, C. Haugen, 2020, Transplantation.

Concerns about the long-term safety of live kidney donors are justified

D. Segev, A. Massie, A. Muzaale, 2017, European Journal of Epidemiology.

Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors

C. Lewis, B. Julian, D. Segev, 2017, Annals of surgery.

Neutralizing activity and 3-month durability of tixagevimab and cilgavimab prophylaxis against Omicron sublineages in transplant recipients

D. Segev, D. Warren, A. Massie, 2023, American Journal of Transplantation.

Maximizing the use of potential donors through increased rates of family approach for authorization

D. Segev, A. Massie, K. Vanterpool, 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Predicting chance of liver transplantation for pediatric wait‐list candidates

D. Segev, A. Massie, Xun Luo, 2019, Pediatric transplantation.

Early Development and Durability of SARS-CoV-2 Antibodies Among Solid Organ Transplant Recipients: A Pilot Study.

D. Segev, A. Massie, A. Tobian, 2021, Transplantation.

Antibody response to SARS-CoV-2 messenger RNA vaccines in liver transplant recipients.

D. Segev, A. Massie, A. Tobian, 2021, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Antibody response to a third dose of SARS‐CoV‐2 vaccine in heart and lung transplant recipients

D. Segev, D. Warren, A. Massie, 2022, Clinical transplantation.

Incidence and Severity of COVID-19 Among Vaccinated Solid Organ Transplant Recipients During the Omicron Wave.

D. Segev, D. Warren, A. Massie, 2022, Transplantation.

Outcomes of SOT Recipients With COVID-19 in Different Eras of COVID-19 Therapeutics

Chiung-Yu Huang, P. Shah, C. Merlo, 2021, Transplantation direct.

Mortality and Graft Loss Attributable to Readmission After Kidney Transplantation: Immediate and Long-term Risk

L. Kucirka, D. Segev, A. Massie, 2017, Transplantation.

Antibody Response to a Fourth Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: An Update

D. Segev, D. Warren, A. Massie, 2022, Transplantation.

Antibody Response to Severe Acute Respiratory Syndrome‐Coronavirus‐2 Messenger RNA Vaccines in Liver Transplant Recipients

D. Segev, A. Massie, A. Tobian, 2021, Liver Transplantation.

Antibody durability 6 months after two doses of SARS-CoV-2 mRNA vaccines in patients with rheumatic and musculoskeletal disease

D. Segev, A. Massie, L. Christopher‐Stine, 2022, The Lancet Rheumatology.

Who can tolerate a marginal kidney? Predicting survival after deceased donor kidney transplant by donor–recipient combination

J. Coresh, D. Segev, A. Massie, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Effect of maternal multiple micronutrient vs iron-folic acid supplementation on infant mortality and adverse birth outcomes in rural Bangladesh: the JiVitA-3 randomized trial.

A. Massie, A. Labrique, R. Klemm, 2014, JAMA.

COVID-19 Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients

D. Segev, A. Massie, R. Avery, 2021, Clinical Infectious Diseases.

Immunosuppression practices during the COVID‐19 pandemic: A multinational survey study of transplant programs

D. Segev, A. Massie, M. Cantarovich, 2021, Clinical transplantation.

The Effects of DonorNet 2007 on Kidney Distribution Equity and Efficiency

S. Zeger, D. Segev, R. Montgomery, 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Prospective Validation of Prediction Model for Kidney Discard

D. Segev, A. Massie, Sheng Zhou, 2019, Transplantation.

Trends in Heart and Lung Transplantation in the United States Across the COVID-19 Pandemic

R. Higgins, D. Segev, J. Snyder, 2021, Transplantation direct.

Outcomes after liver transplantation using deceased after circulatory death donors: A comparison of outcomes in the UK and the US

D. Segev, A. Massie, J. H. van der Meulen, 2023, Liver international : official journal of the International Association for the Study of the Liver.

Liver transplantation and waitlist mortality for HCC and non‐HCC candidates following the 2015 HCC exception policy change

D. Segev, A. Massie, M. Henderson, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Hospital cost implications of increased use of minimally invasive surgery.

Mo Zhou, Martin A Makary, M. Makary, 2015, JAMA surgery.

Reduced Racial Disparity in Kidney Transplant Outcomes in the United States from 1990 to 2012.

Xun Luo, Tanjala S. Purnell, L. Kucirka, 2016, Journal of the American Society of Nephrology : JASN.

Kidney Dyads: Caregiver Burden and Relationship Strain Among Partners of Dialysis and Transplant Patients

D. Segev, A. Massie, D. Brennan, 2020, Transplantation direct.

The effect of induction immunosuppression for kidney transplant on the latent HIV reservoir

R. Siliciano, T. Quinn, D. Segev, 2022, JCI insight.

Early Hospital Readmission After Simultaneous Pancreas–Kidney Transplantation: Patient and Center‐Level Factors

L. Kucirka, D. Segev, A. Massie, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Influence of Nonclinical Factors on Choice of Therapy for Early Hepatocellular Carcinoma

M. Choti, T. Pawlik, D. Segev, 2013, Annals of Surgical Oncology.

Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases

D. Segev, A. Massie, L. Christopher‐Stine, 2021, Annals of the Rheumatic Diseases.

Effects of COVID19 Pandemic on Pediatric Kidney Transplant in the United States

D. Segev, A. Massie, R. Avery, 2020, Research square.

Trends in the timing of pre-emptive kidney transplantation.

J. Coresh, D. Segev, A. Massie, 2011, Journal of the American Society of Nephrology : JASN.

Persistent SARS-CoV-2–specific immune defects in kidney transplant recipients following third mRNA vaccine dose

S. Klein, D. Segev, D. Warren, 2023, American Journal of Transplantation.

Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series

Ami A. Shah, D. Segev, A. Massie, 2021, Annals of the Rheumatic Diseases.

Neutralizing activity and 3-month durability of tixagevimab and cilgavimab prophylaxis against Omicron sublineages in transplant recipients

D. Segev, D. Warren, A. Massie, 2023, American Journal of Transplantation.

The Aggressive Phenotype Revisited: Utilization of Higher‐Risk Liver Allografts

D. Segev, R. Montgomery, A. Massie, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Six-month Antibody Kinetics and Durability in SARS-CoV-2 mRNA Vaccinated Solid Organ Transplant Recipients

D. Segev, D. Warren, A. Massie, 2021, Transplantation.

Persistent regional and racial disparities in nondirected living kidney donation

D. Segev, A. Massie, Xun Luo, 2017, Clinical transplantation.

Temporal changes in the composition of a large multicenter kidney exchange clearinghouse: Do the hard‐to‐match accumulate?

A. Waterman, D. Segev, S. Gentry, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Center‐Level Utilization of Kidney Paired Donation

D. Segev, R. Montgomery, S. Gentry, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

MELD Exceptions and Rates of Waiting List Outcomes

B. Caffo, M. Schnitzler, D. Segev, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Self-Reported Incident Hypertension and Long-Term Kidney Function in Living Kidney Donors Compared with Healthy Nondonors.

J. Friedewald, D. Segev, A. Massie, 2019, Clinical journal of the American Society of Nephrology : CJASN.

Risk of ESKD in Older Live Kidney Donors with Hypertension.

J. Coresh, D. Segev, J. Snyder, 2019, Clinical journal of the American Society of Nephrology : CJASN.

Anxiety, depression, and regret of donation in living kidney donors

D. Segev, A. Massie, S. Bae, 2018, BMC Nephrology.

Living kidney donors ages 70 and older: recipient and donor outcomes.

Nathan James, Robert A Montgomery, Mohammed Hoque, 2011, Clinical journal of the American Society of Nephrology : CJASN.

The landscape of international living kidney donation in the United States

D. Segev, A. Massie, K. Lentine, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Early Steroid Withdrawal in Deceased-Donor Kidney Transplant Recipients with Delayed Graft Function.

J. Coresh, D. Segev, A. Massie, 2019, Journal of the American Society of Nephrology : JASN.

Patient and Kidney Allograft Survival with National Kidney Paired Donation.

A. Waterman, D. Segev, D. Leeser, 2020, Clinical journal of the American Society of Nephrology : CJASN.

Landscape of Living Multi-organ Donation in the United States: A Registry-Based Cohort Study.

D. Segev, A. Massie, K. Lentine, 2018, Transplantation.

Incidence of SARS‐CoV‐2 infection among unvaccinated US adults during the Omicron wave

M. Makary, D. Segev, A. Massie, 2022, medRxiv.

Offer Acceptance Patterns for Liver Donors Aged 70 and Older

D. Segev, A. Massie, K. Halazun, 2021, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Gerrymandering for Justice: Redistricting U.S. Liver Allocation

Sommer Gentry, Dorry Segev, Eric Chow, 2015, Interfaces.

Patient and Graft Survival After A1/A2-incompatible Living Donor Kidney Transplantation

D. Segev, A. Massie, Samantha Getsin, 2022, Transplantation direct.

MELD as a metric for survival benefit of liver transplantation

D. Segev, S. Gentry, A. Massie, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Outcomes after declining a steatotic donor liver for liver transplant candidates in the United States.

Jane J. Long, D. Segev, A. Massie, 2019, Transplantation.

Following the Organ Supply: Assessing the Benefit of Inter-DSA Travel in Liver Transplantation

M. Schnitzler, D. Segev, S. Gentry, 2013, Transplantation.

Geographic disparity in deceased-donor liver transplant rates following Share 35.

D. Segev, S. Gentry, E. Chow, 2019, Transplantation.

Uptake and One-Year Outcomes of Lung Transplant for COVID-19

P. Shah, C. Merlo, D. Segev, 2023, The Journal of thoracic and cardiovascular surgery.

Outcomes After Declining Increased Infectious Risk Kidney Offers for Pediatric Candidates in the United States.

D. Segev, A. Massie, A. Neu, 2019, Transplantation.

Patient‐reported outcomes after Tixagevimab and Cilgavimab pre‐exposure prophylaxis among solid organ transplant recipients: Safety, effectiveness, and perceptions of risk

D. Segev, A. Massie, A. Tobian, 2023, Clinical transplantation.

Persistent SARS-CoV-2–specific immune defects in kidney transplant recipients following third mRNA vaccine dose

S. Klein, D. Segev, D. Warren, 2023, American Journal of Transplantation.

Erratum: Survival benefit of primary deceased donor transplantation with high-KDPI kidneys (American Journal of Transplantation (2014) 14 (2310-2316) DOI: 10.1111/ajt.12830)

D. Segev, E. Chow, A. Massie, 2015 .

Improving Distribution Efficiency of Hard‐to‐Place Deceased Donor Kidneys: Predicting Probability of Discard or Delay

D. Segev, R. Montgomery, A. Massie, 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

If You're Not Fit, You Mustn't Quit: Observational Studies and Weighing the Evidence

D. Segev, J. Schold, A. Massie, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Mortality and Access to Kidney Transplantation in Patients with Sickle Cell Disease-Associated Kidney Failure.

Tanjala S. Purnell, C. Haywood, D. Segev, 2021, Clinical journal of the American Society of Nephrology : CJASN.

Offspring living kidney donors should not be ruled out

D. Segev, A. Massie, Xun Luo, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Minimizing Risks of Liver Transplantation with Steatotic Donor Livers by Preferred Recipient Matching.

Jane J. Long, D. Segev, A. Massie, 2019, Transplantation.

One Size Does Not Fit All—Regional Variation in the Impact of the Share 35 Liver Allocation Policy

B. Samstein, A. Massie, S. Knechtle, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Efficacy of Antenatal Multiple Micronutrient (MM) vs Iron‐Folic Acid (IFA) Supplementation in Improving Gestational and Postnatal Viability in Rural Bangladesh: The JiVitA‐3 Trial

J. Katz, A. Massie, A. Labrique, 2013 .

Consent and labeling in the use of infectious risk donor kidneys: A response to “Information Overload”

D. Segev, A. Massie, M. Henderson, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Recipient age and outcome after pancreas transplantation: a retrospective dual‐center analysis

F. Messner, A. Massie, S. Benjamens, 2021, Transplant international : official journal of the European Society for Organ Transplantation.

Short Report: Evaluating the Effects of Automated Donor Referral Technology on Deceased Donor Referrals

D. Segev, A. Massie, Macey L. Levan, 2022, Transplantation direct.

Trends in the Inactive Kidney Transplant Waitlist and Implications for Candidate Survival

D. Segev, J. Schold, A. Massie, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Outcome implications of benzodiazepine and opioid co‐prescription in kidney transplant recipients

B. Kasiske, M. Schnitzler, D. Segev, 2020, Clinical transplantation.

Cancer Risk Following HLA-Incompatible Living Donor Kidney Transplantation

R. Pfeiffer, D. Segev, A. Massie, 2023, Transplantation direct.

Quantifying infection risks in incompatible living donor kidney transplant recipients

D. Segev, J. Hiller, R. Montgomery, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Trends and three-year outcomes of hepatitis C virus–viremic donor heart transplant for hepatitis C virus–seronegative recipients

D. Segev, A. Massie, A. Kilic, 2022, JTCVS open.

MELD is MELD is MELD? Transplant center–level variation in waitlist mortality for candidates with the same biological MELD

D. Segev, S. Gentry, A. Massie, 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

MELD allocation system: There is always space to improve

D. Segev, S. Gentry, A. Massie, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Geographic Disparity in Liver Allocation: Time to Act or Have Others Act for Us.

A. Massie, J. Roberts, 2017, Transplantation.

Association Between Living Kidney Donor Postdonation Hypertension and Recipient Graft Failure.

D. Segev, A. Massie, C. Haugen, 2020 .

Effect of Mycophenolate Mofetil Dosing on Antibody Response to SARS-CoV-2 Vaccination in Heart and Lung Transplant Recipients

D. Segev, D. Warren, A. Massie, 2022, Transplantation.

Living kidney donors with HIV: experience and outcomes from a case series by the HOPE in Action Consortium

A. K. Agarwal, C. Winkler, T. Muthukumar, 2023, Lancet regional health. Americas.

Maternal morbidity in early pregnancy in rural northern Bangladesh

A. Massie, A. Labrique, R. Klemm, 2012, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Improved humoral immunogenicity with mRNA‐1273 versus BNT162b2 as third vaccine dose among solid organ transplant recipients seronegative after two BNT162b2 doses

D. Segev, D. Warren, A. Massie, 2022, Clinical transplantation.

Minimizing Risks of Liver Transplantation With Steatotic Donor Livers by Preferred Recipient Matching.

Jane J. Long, D. Segev, A. Massie, 2020, Transplantation.

Humoral and Cellular Immune Response to a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients Taking Belatacept.

J. Blankson, D. Segev, D. Warren, 2022, Transplantation.

What's the score? A comparison of deceased donor kidney scoring systems and correlation with graft outcome

A. Massie, R. Munivenkatappa, B. Philosophe, 2020, Clinical transplantation.

210.5: Differential Immunogenicity of mRNA-1273 Versus BNT162b2 as a Third Vaccine Dose for Solid Organ Transplant Recipients Seronegative After Two BNT162b2 Doses.

D. Segev, D. Warren, A. Massie, 2022, Transplantation.

Quantifying the Risk of Incompatible Kidney Transplantation: A Multicenter Study

M. Stegall, D. Gerber, M. Rees, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Association of race and age with survival among patients undergoing dialysis.

L. Kucirka, J. Lessler, D. Segev, 2011, JAMA.

End Stage Renal Disease after Cardiac Transplantation: An 11-Year National Cohort Study

D. Segev, A. Massie, R. Higgins, 2019, The Journal of Heart and Lung Transplantation.

Outcomes of simultaneous pancreas and kidney transplantation based on donor resuscitation

F. Messner, D. Segev, A. Massie, 2020, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Characterizing the risk of HLA-incompatible living donor kidney transplantation in older recipients.

Jane J. Long, M. Stegall, D. Segev, 2023, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors.

M. Stegall, D. Segev, S. Kapur, 2016, The New England journal of medicine.

Patient and Graft Survival After A1/A2-incompatible Living Donor Kidney Transplantation

D. Segev, A. Massie, Samantha Getsin, 2022, Transplantation direct.

Center-level Variation in HLA-incompatible Living Donor Kidney Transplantation Outcomes.

Jane J. Long, M. Stegall, D. Gerber, 2020, Transplantation.

Deceased-Donor Liver Size and the Sex-Based Disparity in Liver Transplantation.

D. Segev, S. Gentry, A. Massie, 2017, Transplantation.

Transplant Candidate Outcomes After Declining a DCD Liver in the United States

Mackenzie A. Eagleson, D. Segev, S. Gentry, 2023, Transplantation.

Survival Benefit of Primary Deceased Donor Transplantation With High‐KDPI Kidneys

D. Segev, E. Chow, A. Massie, 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Octogenarians have worse clinical outcomes after thyroidectomy.

D. Segev, M. Zeiger, A. Massie, 2018, American journal of surgery.

Coronavirus Disease 2019–Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients

D. Segev, A. Massie, R. Avery, 2021, Clinical Infectious Diseases.

Gerrymandering for Justice: Redistricting U.S. Liver Allocation

D. Segev, S. Gentry, E. Chow, 2015, Interfaces.

A competing risks model to estimate the risk of graft failure and patient death after kidney transplantation using continuous donor-recipient age combinations.

A. Massie, B. Döhler, G. Verbeke, 2024, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

COVID-19 and Access to Kidney Transplantation for Older Candidates in the United States: A National Registry Study

A. Massie, Laura B. Zeiser, Amrusha Musunuru, 2023, Kidney medicine.

One Size Does Not Fit All—Regional Variation in the Impact of the Share 35 Liver Allocation Policy

A. Massie, K. Halazun, S. Mohan, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Antibody Response to Severe Acute Respiratory Syndrome‐Coronavirus‐2 Messenger RNA Vaccines in Liver Transplant Recipients

D. Segev, A. Massie, A. Tobian, 2021, Liver Transplantation.

Uptake and 1-year outcomes of lung transplantation for COVID-19

P. Shah, C. Merlo, D. Segev, 2023, The Journal of Thoracic and Cardiovascular Surgery.

A cluster-randomized, placebo-controlled, maternal vitamin a or beta-carotene supplementation trial in bangladesh: design and methods

A. Massie, A. Labrique, R. Klemm, 2011, Trials.